Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Diabetes Drugs Sales Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

In this report, the global Diabetes Drugs market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Drugs for these regions, from 2014 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Diabetes Drugs market competition by top manufacturers/players, with Diabetes Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Sanofi
Novartis
Abbott
GSK
Merck
Roche
Eli Lilly
B. Braun Melsungen
AstraZeneca
Bayer
DexCom
LTS
J&J
Indivior
Johnson & Johnson
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Sulphonylureas
Biguanides
Meglitinides
Thiazolidinediones
Alpha-glucosidase inhibitors
DPP-4 inhibitors
SGLT-2 inhibitors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Diabetes Drugs for each application, including
Type I Diabetes
Type II Diabetes

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Diabetes Drugs Sales Market Report 2019
1 Diabetes Drugs Market Overview
1.1 Product Overview and Scope of Diabetes Drugs
1.2 Classification of Diabetes Drugs by Product Category
1.2.1 Global Diabetes Drugs Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 Global Diabetes Drugs Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Sulphonylureas
1.2.4 Biguanides
1.2.5 Meglitinides
1.2.6 Thiazolidinediones
1.2.7 Alpha-glucosidase inhibitors
1.2.8 DPP-4 inhibitors
1.2.9 SGLT-2 inhibitors
1.3 Global Diabetes Drugs Market by Application/End Users
1.3.1 Global Diabetes Drugs Sales (Volume) and Market Share Comparison by Application (2014-2024)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Diabetes Drugs Market by Region
1.4.1 Global Diabetes Drugs Market Size (Value) Comparison by Region (2014-2024)
1.4.2 United States Diabetes Drugs Status and Prospect (2014-2024)
1.4.3 China Diabetes Drugs Status and Prospect (2014-2024)
1.4.4 Europe Diabetes Drugs Status and Prospect (2014-2024)
1.4.5 Japan Diabetes Drugs Status and Prospect (2014-2024)
1.4.6 Southeast Asia Diabetes Drugs Status and Prospect (2014-2024)
1.4.7 India Diabetes Drugs Status and Prospect (2014-2024)
1.5 Global Market Size (Value and Volume) of Diabetes Drugs (2014-2024)
1.5.1 Global Diabetes Drugs Sales and Growth Rate (2014-2024)
1.5.2 Global Diabetes Drugs Revenue and Growth Rate (2014-2024)

2 Global Diabetes Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Diabetes Drugs Market Competition by Players/Suppliers
2.1.1 Global Diabetes Drugs Sales and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Global Diabetes Drugs Revenue and Share by Players/Suppliers (2014-2019)
2.2 Global Diabetes Drugs (Volume and Value) by Type
2.2.1 Global Diabetes Drugs Sales and Market Share by Type (2014-2019)
2.2.2 Global Diabetes Drugs Revenue and Market Share by Type (2014-2019)
2.3 Global Diabetes Drugs (Volume and Value) by Region
2.3.1 Global Diabetes Drugs Sales and Market Share by Region (2014-2019)
2.3.2 Global Diabetes Drugs Revenue and Market Share by Region (2014-2019)
2.4 Global Diabetes Drugs (Volume) by Application

3 United States Diabetes Drugs (Volume, Value and Sales Price)
3.1 United States Diabetes Drugs Sales and Value (2014-2019)
3.1.1 United States Diabetes Drugs Sales and Growth Rate (2014-2019)
3.1.2 United States Diabetes Drugs Revenue and Growth Rate (2014-2019)
3.1.3 United States Diabetes Drugs Sales Price Trend (2014-2019)
3.2 United States Diabetes Drugs Sales Volume and Market Share by Players
3.3 United States Diabetes Drugs Sales Volume and Market Share by Type
3.4 United States Diabetes Drugs Sales Volume and Market Share by Application

4 China Diabetes Drugs (Volume, Value and Sales Price)
4.1 China Diabetes Drugs Sales and Value (2014-2019)
4.1.1 China Diabetes Drugs Sales and Growth Rate (2014-2019)
4.1.2 China Diabetes Drugs Revenue and Growth Rate (2014-2019)
4.1.3 China Diabetes Drugs Sales Price Trend (2014-2019)
4.2 China Diabetes Drugs Sales Volume and Market Share by Players
4.3 China Diabetes Drugs Sales Volume and Market Share by Type
4.4 China Diabetes Drugs Sales Volume and Market Share by Application

5 Europe Diabetes Drugs (Volume, Value and Sales Price)
5.1 Europe Diabetes Drugs Sales and Value (2014-2019)
5.1.1 Europe Diabetes Drugs Sales and Growth Rate (2014-2019)
5.1.2 Europe Diabetes Drugs Revenue and Growth Rate (2014-2019)
5.1.3 Europe Diabetes Drugs Sales Price Trend (2014-2019)
5.2 Europe Diabetes Drugs Sales Volume and Market Share by Players
5.3 Europe Diabetes Drugs Sales Volume and Market Share by Type
5.4 Europe Diabetes Drugs Sales Volume and Market Share by Application

6 Japan Diabetes Drugs (Volume, Value and Sales Price)
6.1 Japan Diabetes Drugs Sales and Value (2014-2019)
6.1.1 Japan Diabetes Drugs Sales and Growth Rate (2014-2019)
6.1.2 Japan Diabetes Drugs Revenue and Growth Rate (2014-2019)
6.1.3 Japan Diabetes Drugs Sales Price Trend (2014-2019)
6.2 Japan Diabetes Drugs Sales Volume and Market Share by Players
6.3 Japan Diabetes Drugs Sales Volume and Market Share by Type
6.4 Japan Diabetes Drugs Sales Volume and Market Share by Application

7 Southeast Asia Diabetes Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Diabetes Drugs Sales and Value (2014-2019)
7.1.1 Southeast Asia Diabetes Drugs Sales and Growth Rate (2014-2019)
7.1.2 Southeast Asia Diabetes Drugs Revenue and Growth Rate (2014-2019)
7.1.3 Southeast Asia Diabetes Drugs Sales Price Trend (2014-2019)
7.2 Southeast Asia Diabetes Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Diabetes Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Diabetes Drugs Sales Volume and Market Share by Application

8 India Diabetes Drugs (Volume, Value and Sales Price)
8.1 India Diabetes Drugs Sales and Value (2014-2019)
8.1.1 India Diabetes Drugs Sales and Growth Rate (2014-2019)
8.1.2 India Diabetes Drugs Revenue and Growth Rate (2014-2019)
8.1.3 India Diabetes Drugs Sales Price Trend (2014-2019)
8.2 India Diabetes Drugs Sales Volume and Market Share by Players
8.3 India Diabetes Drugs Sales Volume and Market Share by Type
8.4 India Diabetes Drugs Sales Volume and Market Share by Application

9 Global Diabetes Drugs Players/Suppliers Profiles and Sales Data
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Diabetes Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business/Business Overview
9.2 Sanofi
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Diabetes Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business/Business Overview
9.3 Novartis
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Diabetes Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business/Business Overview
9.4 Abbott
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Diabetes Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Abbott Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business/Business Overview
9.5 GSK
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Diabetes Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GSK Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business/Business Overview
9.6 Merck
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Diabetes Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Merck Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business/Business Overview
9.7 Roche
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Diabetes Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Roche Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business/Business Overview
9.8 Eli Lilly
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Diabetes Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eli Lilly Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business/Business Overview
9.9 B. Braun Melsungen
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Diabetes Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 B. Braun Melsungen Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business/Business Overview
9.10 AstraZeneca
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Diabetes Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 AstraZeneca Diabetes Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business/Business Overview
9.11 Bayer
9.12 DexCom
9.13 LTS
9.14 J&J
9.15 Indivior
9.16 Johnson & Johnson

10 Diabetes Drugs Maufacturing Cost Analysis
10.1 Diabetes Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Diabetes Drugs
10.3 Manufacturing Process Analysis of Diabetes Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Diabetes Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2018
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Diabetes Drugs Market Forecast (2019-2024)
14.1 Global Diabetes Drugs Sales Volume, Revenue and Price Forecast (2019-2024)
14.1.1 Global Diabetes Drugs Sales Volume and Growth Rate Forecast (2019-2024)
14.1.2 Global Diabetes Drugs Revenue and Growth Rate Forecast (2019-2024)
14.1.3 Global Diabetes Drugs Price and Trend Forecast (2019-2024)
14.2 Global Diabetes Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2024)
14.2.1 Global Diabetes Drugs Sales Volume and Growth Rate Forecast by Regions (2019-2024)
14.2.2 Global Diabetes Drugs Revenue and Growth Rate Forecast by Regions (2019-2024)
14.2.3 United States Diabetes Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.4 China Diabetes Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.5 Europe Diabetes Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.6 Japan Diabetes Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.7 Southeast Asia Diabetes Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.2.8 India Diabetes Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2024)
14.3 Global Diabetes Drugs Sales Volume, Revenue and Price Forecast by Type (2019-2024)
14.3.1 Global Diabetes Drugs Sales Forecast by Type (2019-2024)
14.3.2 Global Diabetes Drugs Revenue Forecast by Type (2019-2024)
14.3.3 Global Diabetes Drugs Price Forecast by Type (2019-2024)
14.4 Global Diabetes Drugs Sales Volume Forecast by Application (2019-2024)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us